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Abstract
Background: Glutathione and glutathione metabolism enzymes are essential for the normal functioning of cells and tissues and maintenance of body 
homeostasis. The aim of our study was to investigate the influence of the new Schiff bases, and their combinations with 3d metals, on the glutathione 
metabolism in the liver in physiological conditions.
Material and methods: An experimental study of laboratory animals (rats) was performed. New local biologically active compounds (BAC) – CMD-4, 
CMD-8 and CMJ-23, were injected to healthy rats for 14 days. The content of glutathione (total, reduced and oxidized) and the activity of glutathione 
reductase (GR), glutathione peroxidase (GPO), glutathione-S-transferase (GST) and glutaredoxin (GRX) were determined in the liver homogenates.
results: All tested BAC statistically significant decreased the level of reduced and total glutathione (about 20-30%), and GMJ-23 also reduced the oxidized 
glutathione in the liver (-48%, p<0.05). Influence on the activity of enzymes of glutathione metabolism was more ambiguous. Administration of CMD-4, 
CMD-8 and CMJ-23 did not produce conclusive changes of the enzyme activity of the glutathione metabolism, and their induction had only tendency 
of GR, GST and GRX activity decrease, while CMT-28 and CMT-67 preferentially modulated the activity of enzymes.
conclusions: Local BAC exerts an individual influence on the glutathione metabolism in physiological conditions, which may be used for a particular 
regulation of the processes according to the cell needs.
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Introduction
Glutathione (GSH) and glutathione metabolism enzymes 
are essential for normal cellular, tissue and organism functi-
oning. Glutathione is able to neutralize the free radicals and 
other reactive oxygen species, interact with various xenobi-
otics (acetaminophen, bromobenzene, etc.), eliminate some 
carcinogens (formaldehyde), interfere in the metabolism of 
eicosanoids, adjust the level of nitric oxide (NO) through the 
thioredoxin system.  Maintaining the optimal level of gluta-
thione and activity of enzymes of the glutathione metabolism 
is essential for body homeostasis [12, 11, 13]. 
The reactions of production and reduction of mixed disul-
fides, including glutathionylation and deglutathionylation of 
the proteins occur permanently in the cells. These processes 
are catalyzed and directed by several enzymes ‒ a complex 
network of thiol/disulfidoxide reductase, that are located in 
the endoplasmic reticulum. Glutaredoxines (GRX) and thiol-
transferases, which catalyze the reduction of disulfides or of 
the mixed disulfides of GST, belong to this group of enzymes 
[9, 10]. GRX and thioredoxine systems play the protective 
action in patients with cardiovascular diseases and cataract 
by deglutathionylation of cardiac and lens proteins [1, 19].
Thus, the synthesis and testing of new chemical compo-
unds, with the potential to strengthen reserves of intracellular 
glutathione and control the activity of glutathione enzymes, 
present interest for modern biomedical science and practice.
Biologically active compounds (BAC) are represented in 
a very wide area of scientific research, given extremely large 
variety of substances both natural and synthetic, which exerts 
potent action on different processes in living organisms. 
Synthesis of new BAC and study of their prophylactic and/
or therapeutic potential is permanently on the agenda of 
researchers, including those in Moldova.
Several laboratories and scientific groups in Moldova 
(Gulea A. et al. [7, 8], Macaev F. et al. [14], Gudumac V. et 
al. [6]) investigated BAC with various chemical structures, 
physico-chemical and biological actions. Previous research 
of Moldovan scientists has determined that these BAC have 
a great pharmacological potential due to their antimicrobial, 
antifungal, antitumor, cytostatic, immunomodulatory, bone 
formation induction, and hepato-protective action [16, 17, 
15, 18 ].
The aim of our study was to establish the influence of 
the local BAC offered by Professor Aurelian Gulea (CMD-4, 
CMD-8, CMJ-23) on glutathione metabolism in the liver in 
physiological conditions.
Material and methods
The research was approved by the Research Ethics Com-
mittee of the Nicolae Testemitsanu State University of Medi-
cine and Pharmacy (June 20, 2011).
Experiments were done with the male white rats weighing 
160-250 g. All animals were maintained in similar standard 
vivarium conditions. Considering the mechanisms of regu-
lating the circadian biological rhythms (diurnal, seasonal, 
etc.), and their impact on the concentration, structure and 
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distribution of intracellular components [5], experiments were 
done during the same season, and investigation material was 
collected at the same time of the day.
All studied local BAC – CMD-4, CMD-8, CMJ-23 were 
administered intramuscular during14 days with the daily dose 
1,0 mg/kg body weight.
Animals were sacrificed under light anesthesia with 
sulfuric ether, and liver was taken after 24 hours from the 
last administration of BAC. All operations were performed 
at temperature +4oC.  For biochemical investigations livers 
were subjected to homogenization. The whole process of pre-
paring the liver homogenates was determined under specific 
conditions for assessing enzyme activity.
The following indices of glutathione and thiol-disulfide 
metabolism: the level of total, reduced and oxidized glu-
tathione, the content of protein SH-groups, the activity of 
glutathione reductase (GR), glutathione peroxidase (GPO), 
glutathione-S-transferase (GST) and glutaredoxine (GRX) 
were determined in the liver homogenates according to the 
procedures described by Gudumac V. and co-authors [6].
All methods for determination of enzyme activity and 
contents of chemical compounds have been used by tech-
niques in our modification, adapted for application to the 
spectrophotometer Power Wave HT (BioTek Instruments, 
USA) and the microplate spectro-fluorimeter Synergy H1 
(Hydride Reader, BioTek Instruments, USA).
The statistical analysis of the data has been performed 
by non-parametrical Mann-Whitney U-test. The differences 
have been considered significant for p<0.05. The data are 
presented as a M±SEM.
Results and discussion
The research of the local Schiff base BAC showed their 
significant influence on the level of glutathione and content 
of protein SH-groups in physiological conditions (tab. 1).
It was established that content of reduced glutathione was 
significantly higher than of the oxidized glutathione ‒ 11,24 ± 
0,49 μmol/g tissue vs 1,45 ± 0,25 μmol/g tissue (p<0,001) in 
the liver of the control animals. At the same time, the amount 
of protein thiol groups was almost 2 times higher than of the 
total glutathione (p <0,001).
BAC (CMD-4, CMD-8 and CMJ-23) administration at the 
dose of 1,0 mg/kg body weight, induced changes of different 
Table 1
Influence of local BAc on the content of glutathione and protein SH-groups in the liver in physiologic conditions
Experimental 
groups
Total glutathione, 
μmol/g 
Reduced glutathione, 
μmol/g 
Oxidized glutathione, 
μmol/g 
Protein SH-groups 
mol/g 
Control 12,70±0,40100%
11,24±0,49
100%
1,45±0,25
100%
22,11±1,72
(100%)
CMD-4  10,22±0,49*
80,47%
9,06±0,47*
80,60%
1,54±0,39
106,21%
19,92±0,50
(90%)
CMD-8 9,27±0,99**
73,00%
7,94±1,01*
70,64%
1,33±0,23
91,72%
22,37±0,91
(101%)
CMJ-23 9,13±0,58**
71,89%
8,36±0,57*
74,38%
0,76±0,09*
52,41%
21,75±1,50
(98%)
Note: The statistical significance of the differences compared with controls: * - p <0,05, ** - p <0,01.
magnitude of the contents of glutathione and protein thiol 
groups in the liver of the healthy animals.
The contents of total and reduced glutathione were de-
creased by all BAC included in this study. The level of total 
glutathione was decreased by CMD-4 by 20% (p<0,05 in 
both cases), by CMD-8 by approximately 30% (p<0,01, and 
respectively, p<0,05) and CMJ-23 by 26-28% (p<0,01, and 
respectively, p<0,05). At the same time, the level of oxidized 
glutathione was not statistically conclusively influenced by 
the local BAC. Only CMJ-23 reduced by 48% (p<0,05) the 
content of the  oxidized glutathione in the liver of control 
animals (Tab. 1). Values of the protein thiol groups, as well 
were not changed significantly by the tested BAC. Just CMD-4 
induced a descending trend of the level of protein thiol groups 
(-10%, p>0,05).
Local Schiff base type coordination compounds and their 
complexes with metals did not have significant impact on the 
activity of enzymes of the glutathione metabolism (tab. 2). 
Table 2 
Influence of local BAc on glutathione metabolism 
enzymes in the liver in physiologic conditions
Experi-
mental 
groups
GR
(nmol/s∙g 
prot.)
GPO
(nmol/s∙g 
prot.)
GST
(nmol/s∙g 
prot.)
Glutaredo-
xine
 (nmol/s∙g 
prot.)
Control 30,12±2,91(100%)
29,44±2,11
(100%)
31,22±1,92
(100%)
14,16±2,37
(100%)
CMD-4  27,56±1,02
(92%)
29,44±1,73
(100%)
30,07±1,12
(96%)
13,45±3,39
(95%)
CMD-8 24,59±1,71
(82%)
30,39±2,26
(103%)
27,51±1,02
(88%)
12,73±0,89
(90%)
CMJ-23 26,92±1,96
(89%)
31,17±3,43
(106%)
28,18±1,40
(90%)
9,68±0,82
(68%)
Note: GR – glutathione reductase; GPO – glutathione peroxidase; 
GST – glutathione-S-transferase.
None of the studied local BAC produced significant chan-
ges of the activity of GR, GST and glutaredoxine. However, 
all tested BAC induced the decreasing of the GR activity by 
about 8-18% (p>0,05), of GST - by about 4-12% (p>0,05), 
and glutaredoxine - by about 5-32% (p>0,05). Glutathione 
peroxidase activity was not influenced by any of the studied 
BAC, its activity was mantained within 100-106% limits of 
the reference values. 
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Thus, the influence of BAC – CMD-4, CMD-8 and CMJ-
23 didn’t change the activity of GPO, which is needed for the 
reduced glutathione using it for protective function against 
peroxides of lipids. The level of its activity was similar to the 
level of control animals. At that time the activity of GR, which 
is the enzyme for regeneration of the oxidized glutathione 
(GSSG) to its reduced form (GSH),   decreased by action of 
BAC. This causes the depletion of reduced glutathione and the 
capacity of glutathione system to neutralize various chemical 
compounds.
The results of the influence of local Schiff base type with 
copper-containing coordination compounds ‒ CMT-28 and 
CMT-67, on the activity of glutathione reductase and gluta-
thione peroxidase in the liver in physiological conditions did 
not reveal statistically conclusive changes of the activity of 
these enzymes (fig. 1).
Both compounds increased statistically conclusive activity 
of GR ‒ CMT-28 about 2.6-fold (p<0.001), and CMT-67 about 
3.3-fold (p<0.001) compared to the values found in the ani-
mals of the control group. Activity of glutathione peroxidase 
was not influenced by CMT-28 (98%) and increased after 
administration of CMT-67 by 21% (p<0.01).
At the same time, CMT-67 and CMT-28 decreased statis-
tically significant activity of GST by 40% (p<0.001) and 45% 
(p<0.001), compared to the values identified in the liver of 
the healthy animals (fig. 1).
Thus, the exertions of CMT-28 and CMT-67 provided di-
fferent influence from those specific ones of CMD-4, CMD-8 
and CMJ-23, which opens up possibilities for using the studied 
compounds in order to modulate the activity of enzymes of 
the glutathione metabolism. Considering that maintaining of 
high levels of GSH and decreased values of GSSG is cardinal 
for ongoing of the glutathione-dependent processes, because 
the glutathione realizes its majority of biological functions in 
reduced form, beneficial effect on the metabolism of glutathio-
ne in physiological conditions exert CMT-28 and CMT-67, 
which were increasing the GR activity. The enzyme converts 
oxidized glutathione to GSH, considerably reduces de novo 
synthesis of GSH and maintains the antioxidant activity of 
the enzymes responsible for the reduction of peroxides (GPO, 
GST) and disulfids (glutaredoxins) [3, 20, 21].
System GR-GSH has an important value in maintaining 
of the thiol-disulfide status in mammalian cells. This system 
plays a key role in protecting of cellular macromolecules 
against damage caused by free radicals that are generated in 
excess. Also systems GR-GSH and TrxR/TRX TrxR-TRX are 
involved in several cellular signaling pathways (control the 
activity of transcription factors and other factors that regulate 
apoptosis and cell division). Inhibition of mentioned pathways 
has dual consequences ‒ can induce programmed cell death 
(apoptosis), or increase the sensitivity of cells, including tumor 
cell, to the action of drugs [2, 4, 10].
Conclusions
The exertions of local biologically active compounds 
provided the different influence on the indices of glutathione 
metabolism in the physiological conditions. New Schiff bases 
in combination with 3d-metals, CMD-4, CMD-8 and CMJ-23, 
caused changes in the content of total, reduced and oxidized 
glutathione, but did not act on the activity of enzymes of 
the glutathione metabolism , while CMT-28 and CMT-67 
preferentially modulated the enzyme activity. Thus, for the 
local BAC takes place the specific individual influence on 
the glutathione metabolism, that may be used for a particular 
regulation of the processes according to the cell needs.
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Abstract
Background: Monitoring of aggregate, ward-supply data and analysis of the anatomical therapeutic chemical/defined daily dose system, adjusted for 
bed-occupancy, provides a clear picture of antibiotics consumption frequency and time-trends within hospitals and especially intensive care departments. 
Material and methods: For this study we used data of a five-year (2010-2014) period, in therapeutic intensive care department of the Emergency Medicine 
Institute, which show the consumption dynamics of anti-infectives for systemic use of drugs in grams and value indexes.
results: The defined daily doses (DDD) per 1000 occupied-bed days (DDD/OBD) of antibiotics in therapeutic intensive care department decreased from 
1524 in 2010 to 1206 DDD/1000 in 2014 or by 20.87%, however, it is by 11.77% higher than medium consumption of 1052.25 DDD/1000 in intensive care 
units with the same activity in international hospitals. The value of 54948 lei per DDD/1000 OBD in 2010 recorded a decline to 40754 lei or by 25.84% 
in 2014. The cost of one medium DDD from 36.05 lei in 2010 decreased to 33.77 lei or by 6.33% in 2014. The average antibiotics annual institution 
consumption constituting 464.1 DDD/1000 in 2014 was higher by 1.06% comparatively with medium consumption of 459.20 DDD/1000 registered in 
1706 international hospitals, and by 35.31% in comparison with global consumption of 343 defined daily doses per 1000 patient-days.  
conclusions: The decrease of DDD/1000 OBD and their cost took place as a result of efforts for rational use of antibiotics during the evaluated period. 
Great opportunities were found for improving rational utilization of anti-infectives for systemic use.
Key words: antibiotics, defined daily dose, consumption, rational use, hospitals.
Introduction
The main function of the Therapeutic intensive care de-
partment of Emergency Medicine Institute consists in provi-
ding measures to recover patients after anesthesia of surgical, 
neurosurgical, traumatological and other investigations as 
well as from other possible critical conditions of hospitalized 
patients. Often these patients are exposed to multiple inva-
sive procedures and have to administrate a multiple broad 
spectrum of antibiotics. At the same time, the prescriptions 
are often empiric and lead to overuse or misuse of antibio-
tics, unnecessary side effects, growth of pathogenic microbes 
resistance to antibiotics and increasing treatment costs. The 
above mentioned requires surveillance, stringent consumption 
control and suppose rational antibiotic prescription [1, 2, 3, 
4]. Unfortunately, in the Republic of Moldova the information 
about antibiotics prescription, consumption patterns, and cost 
analysis in hospitals with only few scientific publications [5, 
9, 10, 20] is rather limited.
National Scientific-Practical Centre of Emergency Medici-
ne of the Republic of Moldova reorganized in 2014 into Emer-
